Курение и инфекция
Автор: Дворецкий Л.   



Курение и инфекция

Курение является важным патогенетическим фактором развития различ- ных, главным образом – респираторных инфекций благодаря негативному влиянию на местные защитные механизмы бронхолегочной системы, по- вышенной микробной адгезии к слизистым, активации воспалительных реакций и угнетению звеньев иммунной системы.
Smoking and infection
Smoking is an important pathogenetic factor in the development of different, mostly – respiratory infections due to the negative impact on the local defense mechanisms bronchopulmonary system, increased microbial adhesion to mucous, activation of inflammatory reactions and depression parts of the immune system.


1. Сахарова Г.М., Антонов Н.С. Вредное воздействие табакокурения на здоровье и подходы к лечению табачной зависимости // Справочник поликлинического врача. – 2008; с. 14–15.

2. Доклад Общественной палаты РФ «Табачная эпидемия в России», 2009.

3. U.S. Department of Health and Human Services. The health consequences of involuntary exposure to tobacco smoke: a report of the Surgeon General. Atlanta, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2004.

4. Yeung M., Buncio A. Leukocytecount, smoking, andlungfunction // Am. J. Med.– 1984, 76: 31.

5. Bagaitkar J., Demuth D., Scott David A. Tobacco use in creasessus ceptibility to bacterial infection // Tobacco Ind. Dis. – 2008; 4: 12.

6. Dye J., Adler K. Effects of cigarette smoke on epithelial cells of the respiratory tract // Thorax. – 1994; 49: 825–34.

7. Jones J., Minty B., Lawler P. et al. Increased alveolar epithelial permeability in cigarette smokers // Lancet. – 1980; 1: 66–8.

8. Drannik A., Pouladi M., Robbins C. et al. Impact of cigarette smoke on clearance and inflammation after Pseudomonas aeruginosa infection // Am. J. Respir. Crit. Care Med. – 2004; 170 (11): 1164–71.

9. El Ahmer O., Essery S., Saadi A. et al. The effect of cigarette smoke on adherence of respiratory pathogens to buccal epithelial cells // FEMS Immunol. Med. Microbio. – l999; 23 (1): 27–36.

10. Brook I., Gober A. Effect of smoking cessationon the microbial flora // Arch. Otolaryngol. Head. Neck. Surg. – 2007; 133 (2): 135–8.

11. Wiedeman J., Kaul R., Heuer L. et al. Tobacco smoke induces а persistent infection of Chlamydophila pneumoniaein HEp-2 cells // Microb. Pathog. – 2004; 37 (3): 141–8.

12. Wiedeman J., Kaul R., Heuer L. et al. Tobacco smoke induces a persistent, but recoverable state in Chlamydia pneumoniae infection of human endothelial cells // Microb. Pathog. – 2005; 39 (5–6): 197–204.

13. Zalacain R., Sobradillo V., Amilibia J. et al. Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease // Eur. Respir. J. – 1999; 13 (2): 343–8.

14. Monso E., Garcia-Aymerich J., Soler N. et al. Bacterial infection in exacerbated COPD with changes in sputum characteristics // Epidemiol. Infect. – 2003; 131 (1): 799–804.

15. Tumkaya M., Atis S., Ozge C. et al. Relationship between airway colonization, inflammation and exacerbation frequency in COPD // Respir. Med. – 2007; 101 (4): 729–37.

16. Hament J., Kimpen J., Fleer A. et al. Respiratory viral infection predisposing for bacterial disease: a concise review // FEMS Immunol. Med. Microbiol. – 1999; 26: 189–95.

17. Miyaura S., Eguchi H., Johnston J. Effect of a cigarette smoke extract on the metabolism of the proinflammatory autacoid, platelet-activating factor // Circ. Res. – 1992; 70: 341–7.

18. Ichimaru T., Tai H. Alteration of platelet activating factor (PAF) metabolism in rat pulmonary alveolar macrophages and plasma by cigarette smoking // Prostaglandins Leukot. Essent. Fatty Acids. – 1992; 47: 123–7.

19. Gonzalez-Quintela A., Alende R., Gude F. et al. Serumlevels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities // Clin. Exp. Immunol. – 2008; 151 (1): 42–50.

20. Thatcher T., Benson R., Phipps R. et al. High-dosebutnotlow-dose mainstream cigarette smoke suppresses allergic airway inflammation by inhibiting T cell function // Am. J. Physiol. Lung. Cell. Mol. Physiol. – 2008; 295 (3): 412–21.

21. Straus W., Plouffe J., File T. Jr. et al. Ohio Legionnaires Disease Group, Risk factors for domestic acquisition of legionnaires disease // Arch. Intern. Med. – 1996; 156: 1685–92.

22. Che D., Campese C., Santa-Olalla P. et al. Sporadic community-acquired Legionnaires' disease in France: a 2-year national matched case-control study // Epidemiol. Infect. – 2008; 136 (12): 1684–90.

23. Gaschler G., Skrtic M., Zavitz C. et al. Bacteria challenge in smoke-exposed mice exacerbates inflammation and skews the inflammatory profile // Am. J. Respir. Crit. Care Med. – 2009; 179: 666–75.

24. Chang J., Distler S., Kaplan A. Tobacco smoke suppresses T cells but not antigen-presenting cells in the lung-associated lymph nodes // Toxicol. Appl. Pharmacol. – 1990; 102 (3): 514–23.

25. Hersey P., Prendergast D., Edwards A. Effects of cigarette smoking on the immune system: follow-up studies in normal subjects after cessation of smoking // Med. J. Aust. – 1983; 2: 425–9.

26. Costabel U., Bross K., Reuter C. et al. Alterations in immunoregulatory T-cell subsets in cigarette smokers: a phenotypic analysis of bronchoalveolar and blood lymphocytes // Chest. – 1986; 90: 39–44.

27. Miller L., Goldstein G., Murphy M. et al. Reversible alterations in immunoregulatory T cells in smoking: analysis by monoclonal antibodies and flow cytometry // Chest. – 1982; 82: 526–9.

28. Hodge S., Hodge G., Ahern J. et al. Smoking alters alveolar macrophage recognition and phagocyte ability: implication sin chronic obstructive pulmonary disease // Am. J. Respir. Cell. Mol. Biol. – 2007; 37 (6): 748–55.

29. Рalmer R., Wilson R., Hasan A. et al. Mechanisms of action of environmental factors – tobacco smoking // J. Clin. Periodontol. – 2005; 32 (Suppl. 6): 180–95.

30. Zappacosta B., Persichilli S., Minucci A. et al. Effect of aqueous cigarette smoke extract on the chemiluminescence kinetics of polymorphonuclear leukocytes and on their glycolytic and phagocytic activity // Luminescence. – 2001; 16 (5): 315–9.

31. Страчунский Л.С., Козлов С.Н. Макролиды в современной клинической практике / Смоленск: Русич, 1998; 304 с.

32. Bauernfeind A. In vitro activity of diritrimycin in comparison with other new and established macrolides // J. Antimicrob. Chemother. – 1993; 31 (Suppl.): 39–49.

33. Zarogoulidis P., Papanas N., Kioumis I. et al. Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases // Eur. J. Clin. Pharmacol. Epub., 2011.

34. Antibiotics and the Lung. Ed. by M. Cazzola, F. Blasi, S. Ewig. // Eur. Res. Momograph. – 2004; 9: 28.

35. Labro M. Antibiotics as anti-inflammatory drugs // Curr. Op. Investig. Drugs. – 2002; 3: 61–8.

36. Tamaoki J. The effects of macrolides on inflammatory cells // Chest. – 2004; 125 (Suppl.): 41–51.

37. Equi A., Balfour-Lynn I., Bush A. et al. Long term azithromycin in children with cystic fibrosis: a randomized, placebo-controlled crossover trial // Lancet. – 2002; 360: 978–84.

38. Amsden G. Anti-inflammatory effects of macrolides – an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions // J. Antimicrob. Chemother. – 2005; 55 (1): 10–21.

39. Panpanich R. et. al. Antibiotics for treating scrub typhus // Cochrane Database Syst. Rev. – 2008; 1: CD00195.

40. Murray J. et. al. Efficacy and safety of a novel, single-dose azithromycin microsphere formulation versus 10 days of levofloxacin for the treatment of acute bacterial sinusitis in adults // Otolaryngol. Head. Neck. Surg. – 2005; 133 (2): 194–200.

41. Sopori M. Effects of cigarette smoke on the immune system // Nat. Rev. Immunol. – 2002; 2 (5): 372–7.




→ Фармакопейные статьи

→ Медицинские архивы на службе современного врача

→ Перечень медицинских технологий

ЭКД архив


Информационные партнеры: